Results 201 to 210 of about 54,733 (297)

Discovery of multidrug efflux pump inhibitors with a novel chemical scaffold. [PDF]

open access: yesBiochim Biophys Acta Gen Subj, 2020
Green AT   +6 more
europepmc   +1 more source

Waste activated sludge high‐rate treatment of septage: Biodegradability studies and contact phase trials towards a cleaner environment

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
Abstract The waste activated sludge high‐rate (WASHR) process, developed in our previous study, is used for septic wastewater treatment. This high‐rate contact stabilization pre‐treatment uses typical waste streams found in wastewater treatment plants to reduce a portion of the loadings on the main treatment trains.
Arman Shirali   +2 more
wiley   +1 more source

Microplastics and nanoplastics in water: Improving removal in wastewater treatment plants with alternative coagulants

open access: yesThe Canadian Journal of Chemical Engineering, EarlyView.
The contaminant removal performance of a conventional coagulant, alum, and alternative coagulants, aluminium chlorohydrate (ACH) and ACH + pDADMC, are compared in challenging wastewater treatment conditions (pH >7.8). The interactions of each coagulant with a negatively charged surface are depicted based on quartz crystal microbalance with dissipation ...
Sinan Abi Farraj   +3 more
wiley   +1 more source

A Streamlined High Performance Liquid Chromatography with Tandem Mass Spectrometry Based Workflow for Rapid Screening of Cellular Accumulation of Small Molecules

open access: yesChemMedChem, EarlyView.
This study uses six small‐molecule inhibitors to evaluate optimal cellular accumulation assay conditions in a 96‐well format with high performance liquid chromatography with tandem mass spectrometry detection. The obtained medium to high‐throughput workflow is suitable for reliably identifying cellular accumulation, valuable for preclinical selection ...
Alina Metzen, Katharina Rox
wiley   +1 more source

Repurposing approved drugs as potential efflux pump inhibitors in multidrug-resistant <i>Pseudomonas aeruginosa</i>. [PDF]

open access: yesFuture Microbiol
de Melo Guedes GM   +11 more
europepmc   +1 more source

Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling

open access: yesDevelopmental Dynamics, EarlyView.
Abstract Background Sporadic venous malformation (VM) is associated with the hyperactivating p.L914F mutation in TIE2, a receptor tyrosine kinase essential for vascular development. This mutation is not found in hereditary VM, suggesting incompatibility with life when expressed during early vascular development.
Lindsay J. Bischoff   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy